As CEO of SCRI, Dee Anna Smith leads the organization’s overall mission and vision to make a global impact on the next generation of cancer care.
Under her leadership, SCRI formed a joint venture with US Oncology Research in 2022, bringing together physicians who are actively accruing patients to clinical trials at more than 250 locations in 24 states across the U.S.
Prior to creating the SCRI joint venture, she served as CEO for Sarah Cannon, the Cancer Institute of HCA Healthcare. During her tenure, the company experienced exponential growth across its care network, and conducted pivotal clinical research that led to the majority of newly-approved cancer therapies now available to patients.
As an entrepreneur, Smith founded two companies focused on clinical trial services; the first startup, SiteWorks Solutions, was acquired by Oracle and the second, Summit Research Solutions, was acquired by HCA Healthcare to become a part of SCRI. Smith began her career as an auditor and Certified Public Accountant (CPA) with KPMG, after receiving a bachelor’s degree in Accounting from Pepperdine University.
She is a member of the American Institute of Certified Public Accountants and the American Society of Clinical Oncology. She is the chair of the Pepperdine University Board of Regents, and also serves on the board of directors for the Nashville Health Care Council.